Pseudocirrhosis After Anti-EGFR-Based Neoadjuvant Therapy for Hepatic Metastasis From Colon Cancer: A Different Point of View.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Works matching IS 15330028 AND DT 2014 AND VI 13 AND IP 3
Results: 12
1
2
Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
3
An aggressive presentation of colorectal cancer with an atypical lymphoproliferative pattern of metastatic disease: a case report and review of the literature.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
4
Efficacy and Safety of Single Agent or Combination Adjuvant Chemotherapy in Elderly Patients With Colon Cancer: A Canadian Cancer Institute Experience.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 199, doi. 10.1016/j.clcc.2014.06.002
- By:
- Publication type:
- Article
5
Patterns of Use and Tolerance of Anti--Epidermal Growth Factor Receptor Antibodies in Older Adults With Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 192, doi. 10.1016/j.clcc.2014.05.003
- By:
- Publication type:
- Article
6
Adjuvant Treatment for Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy: When, and for Whom?
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 185, doi. 10.1016/j.clcc.2014.05.004
- By:
- Publication type:
- Article
7
Metastatic Colorectal Cancer Treatment Patterns According to Kirsten Rat Sarcoma Viral Oncogene Homolog Genotype in U.S. Community-Based Oncology Practices.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 178, doi. 10.1016/j.clcc.2014.05.001
- By:
- Publication type:
- Article
8
CAPOX Associated With Toxicities of Higher Grade but Improved Disease-Free Survival When Compared With FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 172, doi. 10.1016/j.clcc.2014.01.001
- By:
- Publication type:
- Article
9
Randomized Phase II Open-Label Study of mFOLFOX6 in Combination With Linifanib or Bevacizumab for Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 156, doi. 10.1016/j.clcc.2014.04.001
- By:
- Publication type:
- Article
10
Adaptation of International Guidelines for Metastatic Colorectal Cancer: An Asian Consensus.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 145, doi. 10.1016/j.clcc.2014.06.004
- By:
- Publication type:
- Article
11
Sequencing of Antiangiogenic Agents in the Treatment of Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 135, doi. 10.1016/j.clcc.2014.02.001
- By:
- Publication type:
- Article
12
Progression-Free Survival Remains Poor Over Sequential Lines of Systemic Therapy in Patients With BRAF-Mutated Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2014, v. 13, n. 3, p. 164, doi. 10.1016/j.clcc.2014.06.001
- By:
- Publication type:
- Article